Applied DNA Sciences, Inc. (BNBX)
NASDAQ: BNBX · Real-Time Price · USD
3.800
+0.050 (1.33%)
At close: Oct 28, 2025, 4:00 PM EDT
3.830
+0.030 (0.79%)
After-hours: Oct 28, 2025, 5:44 PM EDT
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$77,980
Profits / Employee
$847,396
Market Cap
4.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 48 | -7 | -12.73% |
| Sep 30, 2023 | 55 | -14 | -20.29% |
| Sep 30, 2022 | 69 | -32 | -31.68% |
| Sep 30, 2021 | 101 | 40 | 65.57% |
| Sep 30, 2020 | 61 | 10 | 19.61% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BNBX News
- 10 hours ago - BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update - Business Wire
- 6 days ago - Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million - Business Wire
- 22 days ago - Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy - Business Wire
- 4 weeks ago - Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation - Business Wire
- 5 weeks ago - Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - Accesswire
- 2 months ago - Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - Accesswire
- 3 months ago - Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Accesswire
- 4 months ago - Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Accesswire